Floatz logo

513 assets in Ovarian Cancer

Therapeutic assets addressing Ovarian Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Olaparib
Ovarian Cancer
Shandong UniversityP4BB (69)
Cis-Diamminedichloroplatinum Ii
Ovarian Cancer
Kalinski, Pawel, MD, PhDP3BB (68)
Adriamycin
Ovarian Cancer
GenmabP3BB (67)
Carboplatin
Ovarian Cancer
Fudan UniversityP4BB (67)
Irinotecan
Ovarian Cancer
ARCAGY/ GINECO GROUPP4BB (67)
OTL-38
Ovarian Cancer
On Target Laboratories, LLCP4BB (67)
Nogitecan
Ovarian Cancer
GenmabP3BB (66)
Realgar-Indigo Naturalis Formulation
Ovarian Cancer
Peking University People's HospitalP4BB (65)
Cyclophosphamide
Ovarian Cancer
Kalinski, Pawel, MD, PhDP3BB (64)
Docetaxel
Ovarian Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P3BB (64)
Nivestim
Ovarian Cancer
ARCAGY/ GINECO GROUPP3BB (64)
Rivoceranib
Ovarian Cancer
Peking Union Medical College HospitalP4BB (64)
Stenoparib
Ovarian Cancer
Allarity TherapeuticsP2BB (64)
Catequentinib
Ovarian Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4B (63)
Dexasone
Ovarian Cancer
Seoul National University HospitalP4B (63)
Indocyanine Green
Ovarian Cancer
Istanbul UniversityP4B (63)
Isocyclophosphamide
Ovarian Cancer
Brigham and Women's HospitalP3B (63)
Phosphonic Acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-Bis(Trifluoromethyl)Phenyl]Ethoxy]-3-(4-Fluorophenyl)-4-Morpholinyl]Methyl]-2,5-Dihydro-5-Oxo-1H-1,2,4-Triazol-1-Yl]-
Ovarian Cancer
Sichuan Cancer Hospital and Research InstituteP4B (63)
Tislelizumab
Ovarian Cancer
West China HospitalP3B (63)
Ziv-Aflibercept
Ovarian Cancer
National Cancer Institute (NCI)P2B (63)
Epirubicin
Ovarian Cancer
Kalinski, Pawel, MD, PhDP3B (62)
Fluorouracilum
Ovarian Cancer
Lipomedix Pharmaceuticals Inc.P2B (62)
Immunoglobulin G1 [240-Alanine,241-Alanine], Anti-(Human Folate Receptor ?) (Human Monoclonal Pro1184 ?1-Chain, Complex With Human Monoclonal Pro1184 ?-Chain, Dimer, 214??,214???,226,226?,232,232?,235,235?-Octakis(Thioether) With N6-[39-[Bis(1-Deoxy-D-Glucitol-1-Yl)Amino]-1-Oxo-4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxanonatriacont-1-Yl]-N2-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]-L-Lysyl-L-Valyl-N5-(Aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]Carbonyl]Oxy]Methyl]Phenyl]-L-Ornithinamide
Ovarian Cancer
GenmabP3B (62)
Niraparib
Ovarian Cancer
University of MiamiP4B (62)
Np-G2-044
Ovarian Cancer
Novita Pharmaceuticals, Inc.P2/3B (62)
Trabectedin
Ovarian Cancer
Grupo Español de Investigación en Cáncer de OvarioP4B (62)
Atezolizumab
Ovarian Cancer
OHSU Knight Cancer InstituteP3B (61)
Mirvetuximab Soravtansine
Ovarian Cancer
AbbVieP3B (61)
Pegfilgrastim
Ovarian Cancer
University of California, IrvineP4B (61)
Rucaparib
Ovarian Cancer
pharmaand GmbHP3B (61)
Sargramostim
Ovarian Cancer
Aston Sci. Inc.P2B (61)
Anlotinib Hydrochloride Capsules
Ovarian Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P3B (60)
Aspirin
Ovarian Cancer
H. Lee Moffitt Cancer Center and Research InstituteP4B (60)
Disitamab Vedotin
Ovarian Cancer
Second Xiangya Hospital of Central South UniversityP2B (60)
Fluzoparib
Ovarian Cancer
Shandong UniversityP3B (60)
Ifebemtinib
Ovarian Cancer
InxMed (Shanghai) Co., Ltd.P2B (60)
Ivonescimab
Ovarian Cancer
AkesoP2B (60)
Lurbinectedin
Ovarian Cancer
M.D. Anderson Cancer CenterP3B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Ovarian Cancer
Mayo ClinicP2B (60)
Nivolumab
Ovarian Cancer
Regeneron PharmaceuticalsP2B (60)
Pembrolizumab
Ovarian Cancer
Kalinski, Pawel, MD, PhDP3B (60)
Ropivacaine
Ovarian Cancer
Karolinska InstitutetP3B (60)
Veliparib
Ovarian Cancer
AbbVieP3B (60)
Etoposide
Ovarian Cancer
Fudan UniversityP3B (59)
Fludarabine
Ovarian Cancer
Zelluna Immunotherapy ASP3B (59)
Oxaliplatin
Ovarian Cancer
Qilu Pharmaceutical Co., Ltd.P3B (59)
Capecitabine
Ovarian Cancer
OHSU Knight Cancer InstituteP3B (58)
Chiauranib
Ovarian Cancer
Chipscreen Biosciences, Ltd.P3B (58)
Durvalumab
Ovarian Cancer
British Columbia Cancer AgencyP3B (58)
Everolimus
Ovarian Cancer
Gynaecologisch Oncologisch Centrum ZuidP2/3B (58)
Showing 1 to 50 of 513 assets
PreviousPage 1 of 11Next